We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Making Care Decisions for ICU Patients

By HospiMedica staff writers
Posted on 15 Feb 2005
While a study has found that unrealistic family expectations resulted in the increased use of healthcare resources without noticeable improvement in gravely ill patients in the intensive care unit (ICU), limiting aggressive care to such patients upon arrival might shorten potentially productive lives.

The researchers described this dilemma in the February 2005 issue of the Mayo Clinic Proceedings (Mayo Clinic, Rochester, MN, USA). More...
In the study, they used a computerized system (APACHE III) designed to predict mortality rates in real-time for ICU patients, in order to identify those patients with a very low likelihood of survival. They compared a group of these patients, in which families had unrealistic expectations of survival, with a group in which family expectations were judged appropriate. Although the first group spent four days in the ICU compared to 11 days for the latter group, survival at one year did not differ much in the two groups. Nearly all survivors were severely disabled at discharge and at one year.

"Perhaps the best way to avoid vast expenditures of resources on patients very unlikely to survive is by improving communications between patients, their families, and their caregivers,” said Keith Berge, M.D., a Mayo Clinic anesthesiologist who led the study.

Dr. Berge suggested that increased utilization of advanced directives by patients (offered by only 19% in the study), formal patient-care reviews, and assistance from ethicists and family counselors might better align patient or family expectations with reasonable therapeutic goals. The researchers noted that APACHE III was more than five times more pessimistic than what they themselves observed in their extremely ill subset of patients. They also noted the value of physician insights in interpretations in making care decisions.




Related Links:
Mayo Clinic

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.